Skip to main content

Table 1 Baseline characteristics of study cohort with comparison between the relocation and non-relocation group

From: Incidence and factors associated with geographical relocation in patients receiving renal replacement therapy

 

All patients (n = 24,676)

Relocation (n = 5888,23.9%)

Non-relocation (n = 18,788, 76.1%)

Gender (Male)

15,172 (61.5%)

3498 (59.4%)

11,674 (62.1%)

Age (years)

60.3 (15.4)

55.4 (16.2)

61.8 (14.8)

Race

 Caucasian

18,142 (74.1%)

3876 (66.0%)

14,266 (76.6%)

 Asian

2274 (9.3%)

517 (8.8%)

1757 (9.4%)

 ATSI

2669 (10.9%)

1131 (19.3%)

1538 (8.3%)

 MPI

765 (3.1%)

226 (3.8%)

539 (2.9%)

 Other

635 (2.6%)

121 (2.1%)

514 (2.8%)

Comorbidities

 Any

16,228 (65.8%)

3781 (64.2%)

12,447 (66.2%)

 Diabetes

11,570 (47.0%)

2853 (48.5%)

8717 (46.5%)

 CLD

3021 (12.7%)

641 (11.3%)

2380 (13.1%)

 CAD

8077 (34.7%)

1765 (31.6%)

6312 (35.7%)

 PVD

4306 (18.6%)

993 (17.9%)

3313 (18.8%)

 CerebVD

2775 (11.6%)

610 (10.6%)

5156 (11.9%)

Cause of Primary Renal Disease

 Glomerulonephritis

5494 (22.4%)

1446 (24.6%)

4048 (21.7%)

 Diabetes

8803 (35.9%)

2265 (38.5%)

6538 (35.0%)

 Hypertension

3262 (13.3%)

663 (11.3%)

2599 (13.9%)

 Cystic disease

1751 (7.1%)

392 (6.7%)

1359 (7.3%)

 Other

5242 (21.4%)

1117 (19.0%)

4125 (22.1%)

First RRT modality

 Facility HD

17,363 (70.4%)

5888 (73.8%)

13,015 (69.3%)

 Home Therapies

6430 (26.1%)

1331 (22.6%)

5099 (27.1%)

 Transplant

883 (3.6%)

209 (3.5%)

674 (3.6%)

RRT modality at relocation or censoring

 Facility HD

14,331 (58.1%)

3617 (61.4%)

10,714 (57.0%)

 Home Therapies

5750 (23.3%)

1433 (24.3%)

4317 (23.0%)

 Transplant

4595 (18.6%)

838 (14.2%)

3757 (20.0%)

Urbanity

 Major

16,433 (66.6%)

3652 (62.6%)

12,781 (68.1%)

 Inner Regional

4301 (17.5%)

805 (13.8%)

3496 (18.6%)

 Outer Regional

2397 (9.7%)

599 (10.3%)

1798 (9.6%)

 Remote

635 (2.6%)

214 (3.7%)

421 (2.2%)

 Very Remote

843 (3.4%)

567 (9.7%)

276 (1.5%)

  1. Data expressed as numbers (percentage) or mean (standard deviation)
  2. All variables statistically significant (P < 0.05) except for PVD
  3. Number (%) of missing data: 191 (0.8%) in race, 55 (0.2%) in diabetes status, 875 (3.5%) in chronic lung disease, 1397 (5.7%) in coronary artery disease, 1533 (6.2%) in peripheral vascular disease, 685 (2.8%) in cerebral vascular disease and 124 (0.5%) in cause of primary renal disease,
  4. RRT Renal replacement therapy, HD Hemodialysis, ATSI Australia and Torres Strait Islander, MPI Maori Pacific Islander, CLD Chronic Lung Disease, CAD Coronary artery disease, PVD Peripheral vascular disease, CerebVD Cerebrovascular disease